BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36855998)

  • 1. Elabela-apelin-12, 17, 36/APJ system promotes platelet aggregation and thrombosis via activating the PANX1-P2X7 signaling pathway.
    Chen Z; Luo X; Liu M; Jiang J; Li Y; Huang Z; Wang L; Cao J; He L; Huang S; Hu H; Li L; Chen L
    J Cell Biochem; 2023 Apr; 124(4):586-605. PubMed ID: 36855998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension.
    Song J; Tang J; Zhang Z; Liu Y; Zhong J
    Chin Med J (Engl); 2022 May; 135(9):1019-1026. PubMed ID: 34608073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELABELA-APJ axis protects from pressure overload heart failure and angiotensin II-induced cardiac damage.
    Sato T; Sato C; Kadowaki A; Watanabe H; Ho L; Ishida J; Yamaguchi T; Kimura A; Fukamizu A; Penninger JM; Reversade B; Ito H; Imai Y; Kuba K
    Cardiovasc Res; 2017 Jun; 113(7):760-769. PubMed ID: 28371822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apelin and Elabela/Toddler; double ligands for APJ/Apelin receptor in heart development, physiology, and pathology.
    Kuba K; Sato T; Imai Y; Yamaguchi T
    Peptides; 2019 Jan; 111():62-70. PubMed ID: 29684595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elabela/Toddler and apelin bind differently to the apelin receptor.
    Couvineau P; Llorens-Cortes C; Iturrioz X
    FASEB J; 2020 Jun; 34(6):7989-8000. PubMed ID: 32301550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elabela, a newly discovered APJ ligand: Similarities and differences with Apelin.
    Zhang Y; Wang Y; Lou Y; Luo M; Lu Y; Li Z; Wang Y; Miao L
    Peptides; 2018 Nov; 109():23-32. PubMed ID: 30267732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological functions of Elabela, a novel endogenous ligand of APJ receptor.
    Xu J; Chen L; Jiang Z; Li L
    J Cell Physiol; 2018 Sep; 233(9):6472-6482. PubMed ID: 29350399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Apelin and Elabela Ligands on Apelin Receptor Distinct Signaling Profiles.
    Jiang Y; Yan M; Wang C; Wang Q; Chen X; Zhang R; Wan L; Ji B; Dong B; Wang H; Chen J
    Front Pharmacol; 2021; 12():630548. PubMed ID: 33746758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential Role of the ELABELA-APJ Signaling Pathway in Cardiovascular System Development and Diseases.
    Zhou S; Wang J; Wang Q; Meng Z; Peng J; Song W; Zhou Y; Chen S; Chen F; Sun K
    J Cardiovasc Pharmacol; 2020 Apr; 75(4):284-291. PubMed ID: 32000202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The apelinergic-axis in human preeclamptic pregnancies: A systematic review.
    Georgiadou D; Afink GB; van Dijk M
    Pregnancy Hypertens; 2019 Jul; 17():148-157. PubMed ID: 31487633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Elabela-APJ axis: a promising therapeutic target for heart failure.
    Ma Z; Song JJ; Martin S; Yang XC; Zhong JC
    Heart Fail Rev; 2021 Sep; 26(5):1249-1258. PubMed ID: 32314083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research Progress on Role and Mechanism of Elabela in Organ Fibrosis].
    Zhang Y; Luo PT; Li XY; Cui WP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Apr; 43(2):278-282. PubMed ID: 33966710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elabela and Apelin actions in healthy and pathological pregnancies.
    Eberlé D; Marousez L; Hanssens S; Knauf C; Breton C; Deruelle P; Lesage J
    Cytokine Growth Factor Rev; 2019 Apr; 46():45-53. PubMed ID: 30910349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apela Regulates Fluid Homeostasis by Binding to the APJ Receptor to Activate Gi Signaling.
    Deng C; Chen H; Yang N; Feng Y; Hsueh AJ
    J Biol Chem; 2015 Jul; 290(30):18261-8. PubMed ID: 25995451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system.
    Liu W; Yan J; Pan W; Tang M
    Ann Transl Med; 2020 Mar; 8(5):243. PubMed ID: 32309390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.
    Read C; Nyimanu D; Williams TL; Huggins DJ; Sulentic P; Macrae RGC; Yang P; Glen RC; Maguire JJ; Davenport AP
    Pharmacol Rev; 2019 Oct; 71(4):467-502. PubMed ID: 31492821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.